1. Home
  2. AWX vs LEXX Comparison

AWX vs LEXX Comparison

Compare AWX & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AWX

Avalon Holdings Corporation

HOLD

Current Price

$2.70

Market Cap

10.3M

Sector

Utilities

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$8.30

Market Cap

8.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AWX
LEXX
Founded
1998
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.3M
8.7M
IPO Year
1998
2011

Fundamental Metrics

Financial Performance
Metric
AWX
LEXX
Price
$2.70
$8.30
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
21.5K
106.4K
Earning Date
05-11-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$53,090,000.00
$705,923.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$601.47
P/E Ratio
N/A
N/A
Revenue Growth
3.14
52.05
52 Week Low
$2.40
$0.35
52 Week High
$5.43
$8.26

Technical Indicators

Market Signals
Indicator
AWX
LEXX
Relative Strength Index (RSI) 53.65 93.61
Support Level $2.51 $0.65
Resistance Level $2.81 N/A
Average True Range (ATR) 0.11 0.66
MACD 0.02 0.56
Stochastic Oscillator 47.34 98.93

Price Performance

Historical Comparison
AWX
LEXX

About AWX Avalon Holdings Corporation

Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: